{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:06:13Z","timestamp":1784005573889,"version":"3.55.0"},"reference-count":68,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Recent treatment guidelines state that in patients with asymptomatic brain metastases (BMs), local treatment can be delayed until there is evidence of intracranial progression. However, while patients with symptomatic BMs typically require dexamethasone treatment, recent data on the impact of this medication on the outcomes of patients with BMs are lacking. Therefore, the authors conducted a prospective study to evaluate concomitant dexamethasone treatment in a population of radiosurgically treated patients with BMs from non\u2013small cell lung cancer (NSCLC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This prospective observational study included 129 radiosurgically treated patients with NSCLC BMs, a Karnofsky Performance Status \u2265 70, and no previous radiosurgical treatment. Patients were enrolled in the study between December 2019 and May 2023. For patient allocation, data on concomitant immunotherapy (IT) or targeted therapy (TT) and dexamethasone treatment were analyzed 30 days before and after the first Gamma Knife radiosurgery treatment (GKRS1). A cumulative dose threshold of 100 mg of dexamethasone was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The estimated median survival time after GKRS1 was significantly longer in female patients than in male patients and in patients with concomitant IT or TT versus those without. Of note, patients with a cumulative concomitant dexamethasone dose \u2265 100 mg at GKRS1 had a significantly shorter median survival after GKRS1 than the patients with a dose &lt; 100 mg. Moreover, a univariable followed by multivariable Cox regression model revealed that a cumulative dexamethasone dose \u2265 100 mg at GKRS1 and male sex were independent prognostic factors for an increased risk of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>A cumulative dexamethasone dose \u2265 100 mg within 30 days before and after radiosurgery was identified as an independent risk factor for death. Consequently, even in the modern oncological era, the recommendation to delay local BM treatment should be critically reviewed, as the main reason for dexamethasone treatment is the presence of neurological symptoms caused by larger BMs and perifocal edema. Thus, the study data support early local BM treatment to avoid dexamethasone treatment for neurological symptoms caused by progressive BMs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2024.12.jns241771","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T21:47:57Z","timestamp":1741988877000},"page":"384-395","source":"Crossref","is-referenced-by-count":3,"title":["Effect of cumulative dexamethasone dose on the outcome of patients with radiosurgically treated brain metastases in the era of modern oncological therapy"],"prefix":"10.3171","volume":"143","author":[{"given":"Anna","family":"Cho","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gatterbauer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thore","family":"Jankowski","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Haider","sequence":"additional","affiliation":[{"name":"Department of Biomedical Imaging and Image-guided Therapy, Division of Neuroradiology and Musculoskeletal Radiology, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"T\u00f6gl","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Kapfhammer","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Klinik Penzing, Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schreder","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Klinik Ottakring, Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kirchbacher","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Klinik Ottakring, Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Z\u00f6chbauer-M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Oncology, Medical University of Vienna; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"R\u00f6ssler","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dorfer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Dodier","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian J.","family":"Hochmair","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna North Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josa M.","family":"Frischer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Vienna;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"Suppl 4","key":"b1","series-title":"Ann Oncol","first-page":"iv113","article-title":"Regional treatment of metastasis: role of radiosurgery in brain metastases\u2014gamma knife radiosurgery","volume":"15","author":"Gerosa M","year":"2004","unstructured":"Gerosa M, Nicolato A, Foroni R, Tomazzoli L, Bricolo A. Regional treatment of metastasis: role of radiosurgery in brain metastases\u2014gamma knife radiosurgery. Ann Oncol. 2004;15(Suppl 4):iv113\u2013iv117."},{"issue":"8","key":"b2","series-title":"J Oncol Pract","first-page":"703","article-title":"Stereotactic radiosurgery for treatment of brain metastases","volume":"12","author":"Badiyan SN","year":"2016","unstructured":"Badiyan SN, Regine WF, Mehta M. Stereotactic radiosurgery for treatment of brain metastases. J Oncol Pract. 2016;12(8):703\u2013712."},{"issue":"14","key":"b3","series-title":"J Clin Oncol","first-page":"2865","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan JS","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22(14):2865\u20132872."},{"issue":"5","key":"b4","series-title":"J Clin Oncol","first-page":"492","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum MA","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H,  Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. 2022;40(5):492\u2013516."},{"key":"b5","series-title":"Cancer Treat Rev","first-page":"25","article-title":"Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review","volume":"53","author":"Kroeze SG","year":"2017","unstructured":"Kroeze SG, Fritz C, Hoyer M,  Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review. Cancer Treat Rev. 2017;53:25\u201337."},{"issue":"28","key":"b6","series-title":"J Clin Oncol","first-page":"2872","article-title":"Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer","volume":"36","author":"Arbour KC","year":"2018","unstructured":"Arbour KC, Mezquita L, Long N,  Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer. J Clin Oncol. 2018;36(28):2872\u20132878."},{"issue":"12","key":"b7","series-title":"Cancers (Basel)","first-page":"3668","article-title":"Gamma Knife radiosurgery for brain metastases in non-small cell lung cancer patients treated with immunotherapy or targeted therapy","volume":"12","author":"Cho A","year":"2020","unstructured":"Cho A, Untersteiner H, Hirschmann D,  Gamma Knife radiosurgery for brain metastases in non-small cell lung cancer patients treated with immunotherapy or targeted therapy. Cancers (Basel). 2020;12(12):3668."},{"issue":"4","key":"b8","series-title":"Med J Armed Forces India","first-page":"326","article-title":"Cerebral edema and its management","volume":"59","author":"Jha SK","year":"2003","unstructured":"Jha SK. Cerebral edema and its management. Med J Armed Forces India. 2003;59(4):326\u2013331."},{"issue":"12","key":"b9","series-title":"Childs Nerv Syst","first-page":"2293","article-title":"Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms","volume":"32","author":"Murayi R","year":"2016","unstructured":"Murayi R, Chittiboina P. Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms. Childs Nerv Syst. 2016;32(12):2293\u20132302."},{"issue":"5","key":"b10","series-title":"Radiographics","first-page":"1343","article-title":"Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence","volume":"32","author":"Shah R","year":"2012","unstructured":"Shah R, Vattoth S, Jacob R,  Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographics. 2012;32(5):1343\u20131359."},{"issue":"11","key":"b11","series-title":"Cancer Med","first-page":"4026","article-title":"Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy\u2014a retrospective cohort study","volume":"9","author":"Gatterbauer B","year":"2020","unstructured":"Gatterbauer B, Hirschmann D, Eberherr N,  Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy\u2014a retrospective cohort study. Cancer Med. 2020;9(11):4026\u20134036."},{"issue":"33","key":"b12","series-title":"J Clin Oncol","first-page":"5187","article-title":"RANO 2.0: update to the Response Assessment in Neuro-Oncology criteria for high- and low-grade gliomas in adults","volume":"41","author":"Wen PY","year":"2023","unstructured":"Wen PY, van den Bent M, Youssef G,  RANO 2.0: update to the Response Assessment in Neuro-Oncology criteria for high- and low-grade gliomas in adults. J Clin Oncol. 2023;41(33):5187\u20135199."},{"issue":"1","key":"b13","series-title":"ESMO Open","first-page":"e000457","article-title":"Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors","volume":"4","author":"Fuc\u00e0 G","year":"2019","unstructured":"Fuc\u00e0 G, Galli G, Poggi M,  Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors. ESMO Open. 2019;4(1):e000457."},{"issue":"2","key":"b14","series-title":"Int J Radiat Oncol Biol Phys","first-page":"510","article-title":"A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database","volume":"70","author":"Sperduto PW","year":"2008","unstructured":"Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70(2):510\u2013514."},{"issue":"4","key":"b15","series-title":"Int J Radiat Oncol Biol Phys","first-page":"745","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar L","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M,  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37(4):745\u2013751."},{"issue":"6","key":"b16","series-title":"JAMA Oncol","first-page":"827","article-title":"Estimating survival in patients with lung cancer and brain metastases: an update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)","volume":"3","author":"Sperduto PW","year":"2017","unstructured":"Sperduto PW, Yang TJ, Beal K,  Estimating survival in patients with lung cancer and brain metastases: an update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). JAMA Oncol. 2017;3(6):827\u2013831."},{"issue":"2","key":"b17","series-title":"J Radiosurg","first-page":"89","article-title":"Score index for stereotactic radiosurgery of brain metastases","volume":"1","author":"Weltman E","year":"1998","unstructured":"Weltman E, Salvajoli JV, Oliveira VC,  Score index for stereotactic radiosurgery of brain metastases. J Radiosurg. 1998;1(2):89\u201397."},{"issue":"4","key":"b18","series-title":"Cancer Med","first-page":"1202","article-title":"Midlife brain metastases in the United States: is male at risk?","volume":"11","author":"Che W","year":"2022","unstructured":"Che W, Wang Y, Wang X, Lyu J. Midlife brain metastases in the United States: is male at risk? Cancer Med. 2022;11(4):1202\u20131216."},{"issue":"6","key":"b19","series-title":"Curr Opin Neurol","first-page":"587","article-title":"Combination of radiosurgery and immunotherapy in brain metastases: balance between efficacy and toxicities","volume":"36","author":"Botticella A","year":"2023","unstructured":"Botticella A, Dhermain F. Combination of radiosurgery and immunotherapy in brain metastases: balance between efficacy and toxicities. Curr Opin Neurol. 2023;36(6):587\u2013591."},{"issue":"5","key":"b20","series-title":"Cancers (Basel)","first-page":"1240","article-title":"Oncologic outcome and immune responses of radiotherapy with anti-PD-1 treatment for brain metastases regarding timing and benefiting subgroups","volume":"14","author":"Trommer M","year":"2022","unstructured":"Trommer M, Adams A, Celik E,  Oncologic outcome and immune responses of radiotherapy with anti-PD-1 treatment for brain metastases regarding timing and benefiting subgroups. Cancers (Basel). 2022;14(5):1240."},{"key":"b21","series-title":"Front Oncol","first-page":"154","article-title":"Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions","volume":"8","author":"Hartgerink D","year":"2018","unstructured":"Hartgerink D, van der Heijden B, De Ruysscher D,  Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions. Front Oncol. 2018;8:154."},{"issue":"3","key":"b22","series-title":"Oncoimmunology","first-page":"e1283461","article-title":"Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab","volume":"6","author":"Skrepnik T","year":"2017","unstructured":"Skrepnik T, Sundararajan S, Cui H, Stea B. Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab. Oncoimmunology. 2017;6(3):e1283461."},{"issue":"2","key":"b23","series-title":"Clin Lung Cancer","first-page":"95","article-title":"Efficacy and safety of combined brain radiotherapy and immunotherapy in non-small-cell lung cancer with brain metastases: a systematic review and meta-analysis","volume":"23","author":"Yang Y","year":"2022","unstructured":"Yang Y, Deng L, Yang Y,  Efficacy and safety of combined brain radiotherapy and immunotherapy in non-small-cell lung cancer with brain metastases: a systematic review and meta-analysis. Clin Lung Cancer. 2022;23(2):95\u2013107."},{"issue":"6","key":"b24","series-title":"Cancer Treat Rev","first-page":"503","article-title":"The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant","volume":"41","author":"Reynders K","year":"2015","unstructured":"Reynders K, Illidge T, Siva S, Chang JY, De Ruysscher D. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev. 2015;41(6):503\u2013510."},{"issue":"4","key":"b25","series-title":"J Neurosurg","first-page":"560","article-title":"Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis","volume":"81","author":"Strugar J","year":"1994","unstructured":"Strugar J, Rothbart D, Harrington W, Criscuolo GR. Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg. 1994;81(4):560\u2013566."},{"issue":"10","key":"b26","series-title":"J Neurol","first-page":"1357","article-title":"Management of brain metastases","volume":"249","author":"Soffietti R","year":"2002","unstructured":"Soffietti R, Rud\u0101 R, Mutani R. Management of brain metastases. J Neurol. 2002;249(10):1357\u20131369."},{"issue":"19","key":"b27","series-title":"Cancer","first-page":"4341","article-title":"Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases","volume":"126","author":"Steindl A","year":"2020","unstructured":"Steindl A, Yadavalli S, Gruber KA,  Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases. Cancer. 2020;126(19):4341\u20134352."},{"issue":"2","key":"b28","series-title":"Neurosurgery","first-page":"272","article-title":"The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases","volume":"53","author":"Chang EL","year":"2003","unstructured":"Chang EL, Hassenbusch SJ III, Shiu AS,  The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery. 2003;53(2):272\u2013281."},{"issue":"30","key":"b29","series-title":"J Clin Oncol","first-page":"3606","article-title":"Tyrosine kinase inhibitors with and without up-front stereotactic radiosurgery for brain metastases from EGFR and ALK oncogene-driven non-small cell lung cancer (TURBO-NSCLC)","volume":"42","author":"Pike LRG","year":"2024","unstructured":"Pike LRG, Miao E, Boe LA,  Tyrosine kinase inhibitors with and without up-front stereotactic radiosurgery for brain metastases from EGFR and ALK oncogene-driven non-small cell lung cancer (TURBO-NSCLC). J Clin Oncol. 2024;42(30):3606\u20133617."},{"issue":"2","key":"b30","series-title":"Neuro Oncol","first-page":"242","article-title":"Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose","volume":"21","author":"Moraes FY","year":"2019","unstructured":"Moraes FY, Winter J, Atenafu EG,  Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose. Neuro Oncol. 2019;21(2):242\u2013251."},{"key":"b31","series-title":"Eur J Cancer","first-page":"113542","article-title":"Combined immunotherapy in melanoma patients with brain metastases: a multicenter international study","volume":"199","author":"Mandal\u00e0 M","year":"2024","unstructured":"Mandal\u00e0 M, Lorigan P, Sergi MC,  Combined immunotherapy in melanoma patients with brain metastases: a multicenter international study. Eur J Cancer. 2024;199:113542."},{"issue":"11","key":"b32","series-title":"Anticancer Res","first-page":"5333","article-title":"The role of immune checkpoint inhibitors in leptomeningeal disease: a systematic review","volume":"41","author":"Palmisciano P","year":"2021","unstructured":"Palmisciano P, Haider AS, Nwagwu CD,  The role of immune checkpoint inhibitors in leptomeningeal disease: a systematic review. Anticancer Res. 2021;41(11):5333\u20135342."},{"issue":"18","key":"b33","series-title":"Int J Mol Sci","first-page":"10292","article-title":"Impact of baseline versus intercurrent steroids administration on upfront chemo-immunotherapy for advanced non-small cell lung cancer (NSCLC)","volume":"23","author":"De Giglio A","year":"2022","unstructured":"De Giglio A, Aprile M, Di Federico A,  Impact of baseline versus intercurrent steroids administration on upfront chemo-immunotherapy for advanced non-small cell lung cancer (NSCLC). Int J Mol Sci. 2022;23(18):10292."},{"issue":"2","key":"b34","series-title":"Clin Lung Cancer","first-page":"e180","article-title":"Steroid use independently predicts for poor outcomes in patients with advanced NSCLC and high PD-L1 expression receiving first-line pembrolizumab monotherapy","volume":"22","author":"Mountzios G","year":"2021","unstructured":"Mountzios G, de Toma A, Economopoulou P,  Steroid use independently predicts for poor outcomes in patients with advanced NSCLC and high PD-L1 expression receiving first-line pembrolizumab monotherapy. Clin Lung Cancer. 2021;22(2):e180\u2013e192."},{"issue":"Suppl 4","key":"b1","series-title":"Ann Oncol","first-page":"iv113","article-title":"Regional treatment of metastasis: role of radiosurgery in brain metastases\u2014gamma knife radiosurgery","volume":"15","author":"Gerosa M","year":"2004","unstructured":"Gerosa M, Nicolato A, Foroni R, Tomazzoli L, Bricolo A. Regional treatment of metastasis: role of radiosurgery in brain metastases\u2014gamma knife radiosurgery. Ann Oncol. 2004;15(Suppl 4):iv113\u2013iv117."},{"issue":"8","key":"b2","series-title":"J Oncol Pract","first-page":"703","article-title":"Stereotactic radiosurgery for treatment of brain metastases","volume":"12","author":"Badiyan SN","year":"2016","unstructured":"Badiyan SN, Regine WF, Mehta M. Stereotactic radiosurgery for treatment of brain metastases. J Oncol Pract. 2016;12(8):703\u2013712."},{"issue":"14","key":"b3","series-title":"J Clin Oncol","first-page":"2865","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan JS","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22(14):2865\u20132872."},{"issue":"5","key":"b4","series-title":"J Clin Oncol","first-page":"492","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum MA","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H,  Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. 2022;40(5):492\u2013516."},{"key":"b5","series-title":"Cancer Treat Rev","first-page":"25","article-title":"Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review","volume":"53","author":"Kroeze SG","year":"2017","unstructured":"Kroeze SG, Fritz C, Hoyer M,  Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review. Cancer Treat Rev. 2017;53:25\u201337."},{"issue":"28","key":"b6","series-title":"J Clin Oncol","first-page":"2872","article-title":"Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer","volume":"36","author":"Arbour KC","year":"2018","unstructured":"Arbour KC, Mezquita L, Long N,  Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer. J Clin Oncol. 2018;36(28):2872\u20132878."},{"issue":"12","key":"b7","series-title":"Cancers (Basel)","first-page":"3668","article-title":"Gamma Knife radiosurgery for brain metastases in non-small cell lung cancer patients treated with immunotherapy or targeted therapy","volume":"12","author":"Cho A","year":"2020","unstructured":"Cho A, Untersteiner H, Hirschmann D,  Gamma Knife radiosurgery for brain metastases in non-small cell lung cancer patients treated with immunotherapy or targeted therapy. Cancers (Basel). 2020;12(12):3668."},{"issue":"4","key":"b8","series-title":"Med J Armed Forces India","first-page":"326","article-title":"Cerebral edema and its management","volume":"59","author":"Jha SK","year":"2003","unstructured":"Jha SK. Cerebral edema and its management. Med J Armed Forces India. 2003;59(4):326\u2013331."},{"issue":"12","key":"b9","series-title":"Childs Nerv Syst","first-page":"2293","article-title":"Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms","volume":"32","author":"Murayi R","year":"2016","unstructured":"Murayi R, Chittiboina P. Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms. Childs Nerv Syst. 2016;32(12):2293\u20132302."},{"issue":"5","key":"b10","series-title":"Radiographics","first-page":"1343","article-title":"Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence","volume":"32","author":"Shah R","year":"2012","unstructured":"Shah R, Vattoth S, Jacob R,  Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographics. 2012;32(5):1343\u20131359."},{"issue":"11","key":"b11","series-title":"Cancer Med","first-page":"4026","article-title":"Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy\u2014a retrospective cohort study","volume":"9","author":"Gatterbauer B","year":"2020","unstructured":"Gatterbauer B, Hirschmann D, Eberherr N,  Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy\u2014a retrospective cohort study. Cancer Med. 2020;9(11):4026\u20134036."},{"issue":"33","key":"b12","series-title":"J Clin Oncol","first-page":"5187","article-title":"RANO 2.0: update to the Response Assessment in Neuro-Oncology criteria for high- and low-grade gliomas in adults","volume":"41","author":"Wen PY","year":"2023","unstructured":"Wen PY, van den Bent M, Youssef G,  RANO 2.0: update to the Response Assessment in Neuro-Oncology criteria for high- and low-grade gliomas in adults. J Clin Oncol. 2023;41(33):5187\u20135199."},{"issue":"1","key":"b13","series-title":"ESMO Open","first-page":"e000457","article-title":"Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors","volume":"4","author":"Fuc\u00e0 G","year":"2019","unstructured":"Fuc\u00e0 G, Galli G, Poggi M,  Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors. ESMO Open. 2019;4(1):e000457."},{"issue":"2","key":"b14","series-title":"Int J Radiat Oncol Biol Phys","first-page":"510","article-title":"A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database","volume":"70","author":"Sperduto PW","year":"2008","unstructured":"Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70(2):510\u2013514."},{"issue":"4","key":"b15","series-title":"Int J Radiat Oncol Biol Phys","first-page":"745","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar L","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M,  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37(4):745\u2013751."},{"issue":"6","key":"b16","series-title":"JAMA Oncol","first-page":"827","article-title":"Estimating survival in patients with lung cancer and brain metastases: an update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)","volume":"3","author":"Sperduto PW","year":"2017","unstructured":"Sperduto PW, Yang TJ, Beal K,  Estimating survival in patients with lung cancer and brain metastases: an update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). JAMA Oncol. 2017;3(6):827\u2013831."},{"issue":"2","key":"b17","series-title":"J Radiosurg","first-page":"89","article-title":"Score index for stereotactic radiosurgery of brain metastases","volume":"1","author":"Weltman E","year":"1998","unstructured":"Weltman E, Salvajoli JV, Oliveira VC,  Score index for stereotactic radiosurgery of brain metastases. J Radiosurg. 1998;1(2):89\u201397."},{"issue":"4","key":"b18","series-title":"Cancer Med","first-page":"1202","article-title":"Midlife brain metastases in the United States: is male at risk?","volume":"11","author":"Che W","year":"2022","unstructured":"Che W, Wang Y, Wang X, Lyu J. Midlife brain metastases in the United States: is male at risk? Cancer Med. 2022;11(4):1202\u20131216."},{"issue":"6","key":"b19","series-title":"Curr Opin Neurol","first-page":"587","article-title":"Combination of radiosurgery and immunotherapy in brain metastases: balance between efficacy and toxicities","volume":"36","author":"Botticella A","year":"2023","unstructured":"Botticella A, Dhermain F. Combination of radiosurgery and immunotherapy in brain metastases: balance between efficacy and toxicities. Curr Opin Neurol. 2023;36(6):587\u2013591."},{"issue":"5","key":"b20","series-title":"Cancers (Basel)","first-page":"1240","article-title":"Oncologic outcome and immune responses of radiotherapy with anti-PD-1 treatment for brain metastases regarding timing and benefiting subgroups","volume":"14","author":"Trommer M","year":"2022","unstructured":"Trommer M, Adams A, Celik E,  Oncologic outcome and immune responses of radiotherapy with anti-PD-1 treatment for brain metastases regarding timing and benefiting subgroups. Cancers (Basel). 2022;14(5):1240."},{"key":"b21","series-title":"Front Oncol","first-page":"154","article-title":"Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions","volume":"8","author":"Hartgerink D","year":"2018","unstructured":"Hartgerink D, van der Heijden B, De Ruysscher D,  Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions. Front Oncol. 2018;8:154."},{"issue":"3","key":"b22","series-title":"Oncoimmunology","first-page":"e1283461","article-title":"Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab","volume":"6","author":"Skrepnik T","year":"2017","unstructured":"Skrepnik T, Sundararajan S, Cui H, Stea B. Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab. Oncoimmunology. 2017;6(3):e1283461."},{"issue":"2","key":"b23","series-title":"Clin Lung Cancer","first-page":"95","article-title":"Efficacy and safety of combined brain radiotherapy and immunotherapy in non-small-cell lung cancer with brain metastases: a systematic review and meta-analysis","volume":"23","author":"Yang Y","year":"2022","unstructured":"Yang Y, Deng L, Yang Y,  Efficacy and safety of combined brain radiotherapy and immunotherapy in non-small-cell lung cancer with brain metastases: a systematic review and meta-analysis. Clin Lung Cancer. 2022;23(2):95\u2013107."},{"issue":"6","key":"b24","series-title":"Cancer Treat Rev","first-page":"503","article-title":"The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant","volume":"41","author":"Reynders K","year":"2015","unstructured":"Reynders K, Illidge T, Siva S, Chang JY, De Ruysscher D. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev. 2015;41(6):503\u2013510."},{"issue":"4","key":"b25","series-title":"J Neurosurg","first-page":"560","article-title":"Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis","volume":"81","author":"Strugar J","year":"1994","unstructured":"Strugar J, Rothbart D, Harrington W, Criscuolo GR. Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg. 1994;81(4):560\u2013566."},{"issue":"10","key":"b26","series-title":"J Neurol","first-page":"1357","article-title":"Management of brain metastases","volume":"249","author":"Soffietti R","year":"2002","unstructured":"Soffietti R, Rud\u0101 R, Mutani R. Management of brain metastases. J Neurol. 2002;249(10):1357\u20131369."},{"issue":"19","key":"b27","series-title":"Cancer","first-page":"4341","article-title":"Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases","volume":"126","author":"Steindl A","year":"2020","unstructured":"Steindl A, Yadavalli S, Gruber KA,  Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases. Cancer. 2020;126(19):4341\u20134352."},{"issue":"2","key":"b28","series-title":"Neurosurgery","first-page":"272","article-title":"The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases","volume":"53","author":"Chang EL","year":"2003","unstructured":"Chang EL, Hassenbusch SJ III, Shiu AS,  The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery. 2003;53(2):272\u2013281."},{"issue":"30","key":"b29","series-title":"J Clin Oncol","first-page":"3606","article-title":"Tyrosine kinase inhibitors with and without up-front stereotactic radiosurgery for brain metastases from EGFR and ALK oncogene-driven non-small cell lung cancer (TURBO-NSCLC)","volume":"42","author":"Pike LRG","year":"2024","unstructured":"Pike LRG, Miao E, Boe LA,  Tyrosine kinase inhibitors with and without up-front stereotactic radiosurgery for brain metastases from EGFR and ALK oncogene-driven non-small cell lung cancer (TURBO-NSCLC). J Clin Oncol. 2024;42(30):3606\u20133617."},{"issue":"2","key":"b30","series-title":"Neuro Oncol","first-page":"242","article-title":"Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose","volume":"21","author":"Moraes FY","year":"2019","unstructured":"Moraes FY, Winter J, Atenafu EG,  Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose. Neuro Oncol. 2019;21(2):242\u2013251."},{"key":"b31","series-title":"Eur J Cancer","first-page":"113542","article-title":"Combined immunotherapy in melanoma patients with brain metastases: a multicenter international study","volume":"199","author":"Mandal\u00e0 M","year":"2024","unstructured":"Mandal\u00e0 M, Lorigan P, Sergi MC,  Combined immunotherapy in melanoma patients with brain metastases: a multicenter international study. Eur J Cancer. 2024;199:113542."},{"issue":"11","key":"b32","series-title":"Anticancer Res","first-page":"5333","article-title":"The role of immune checkpoint inhibitors in leptomeningeal disease: a systematic review","volume":"41","author":"Palmisciano P","year":"2021","unstructured":"Palmisciano P, Haider AS, Nwagwu CD,  The role of immune checkpoint inhibitors in leptomeningeal disease: a systematic review. Anticancer Res. 2021;41(11):5333\u20135342."},{"issue":"18","key":"b33","series-title":"Int J Mol Sci","first-page":"10292","article-title":"Impact of baseline versus intercurrent steroids administration on upfront chemo-immunotherapy for advanced non-small cell lung cancer (NSCLC)","volume":"23","author":"De Giglio A","year":"2022","unstructured":"De Giglio A, Aprile M, Di Federico A,  Impact of baseline versus intercurrent steroids administration on upfront chemo-immunotherapy for advanced non-small cell lung cancer (NSCLC). Int J Mol Sci. 2022;23(18):10292."},{"issue":"2","key":"b34","series-title":"Clin Lung Cancer","first-page":"e180","article-title":"Steroid use independently predicts for poor outcomes in patients with advanced NSCLC and high PD-L1 expression receiving first-line pembrolizumab monotherapy","volume":"22","author":"Mountzios G","year":"2021","unstructured":"Mountzios G, de Toma A, Economopoulou P,  Steroid use independently predicts for poor outcomes in patients with advanced NSCLC and high PD-L1 expression receiving first-line pembrolizumab monotherapy. Clin Lung Cancer. 2021;22(2):e180\u2013e192."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/143\/2\/article-p384.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/143\/2\/article-p384.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/143\/2\/article-p384.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:29:45Z","timestamp":1772720985000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/143\/2\/article-p384.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":68,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2024.12.jns241771","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}